TreeWAS – Variant ID: rs116039626

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.980	0.020
T36-T50 Poisoning by drugs, medicaments and biological substances	0.977	0.023
# Top node	0.974	0.026
Chapter XX External causes of morbidity and mortality	0.973	0.027
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.958	0.042
Chapter X Diseases of the respiratory system	0.956	0.044
W00-W19 Falls	0.951	0.049
Chapter V Mental and behavioural disorders	0.948	0.052
W19 Unspecified fall	0.939	0.061
J90-J94 Other diseases of pleura	0.938	0.062
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.933	0.067
F10 Mental and behavioural disorders due to use of alcohol	0.925	0.075
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.920	0.080
J90 Pleural effusion, not elsewhere classified	0.915	0.085
Chapter VIII Diseases of the ear and mastoid process	0.912	0.088
Chapter VII Diseases of the eye and adnexa	0.905	0.095
W19.4 Street and highway	0.905	0.095
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.904	0.096
J09-J18 Influenza and pneumonia	0.902	0.098
T79-T79 Certain early complications of trauma	0.884	0.116
S80-S89 Injuries to the knee and lower leg	0.881	0.119
T50.9 Other and unspecified drugs, medicaments and biological substances	0.880	0.120
F10.1 Harmful use	0.871	0.129
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.858	0.142
S00-S09 Injuries to the head	0.854	0.146
S70-S79 Injuries to the hip and thigh	0.851	0.149
Chapter I Certain infectious and parasitic diseases	0.850	0.150
Chapter XXII Codes for special purposes	0.847	0.153
F10.2 Dependence syndrome	0.845	0.155
T51 Toxic effect of alcohol	0.844	0.156
Y43 Primarily systemic agents	0.836	0.164
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.834	0.166
W19.2 School, other institution and public administrative area	0.833	0.167
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.833	0.167
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.833	0.167
H10-H13 Disorders of conjunctiva	0.828	0.172
H60-H62 Diseases of external ear	0.828	0.172
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.827	0.172
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.823	0.177
H80-H83 Diseases of inner ear	0.822	0.178
J91 Pleural effusion in conditions classified elsewhere	0.822	0.178
Y52 Agents primarily affecting the cardiovascular system	0.816	0.184
T79 Certain early complications of trauma, not elsewhere classified	0.814	0.186
S82 Fracture of lower leg, including ankle	0.813	0.187
Chapter IV Endocrine, nutritional and metabolic diseases	0.812	0.188
J18 Pneumonia, organism unspecified	0.809	0.191
H40-H42 Glaucoma	0.809	0.191
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.808	0.192
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.807	0.193
S60-S69 Injuries to the wrist and hand	0.806	0.194
B95-B98 Bacterial, viral and other infectious agents	0.801	0.199
E20-E35 Disorders of other endocrine glands	0.794	0.206
J40-J47 Chronic lower respiratory diseases	0.790	0.210
F10.0 Acute intoxication	0.790	0.210
F99-F99 Unspecified mental disorder	0.790	0.210
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.789	0.211
X60-X84 Intentional self-harm	0.786	0.214
J15 Bacterial pneumonia, not elsewhere classified	0.785	0.215
Y40 Systemic antibiotics	0.784	0.215
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.783	0.217
H11 Other disorders of conjunctiva	0.782	0.218
H61 Other disorders of external ear	0.779	0.221
T39.1 4-Aminophenol derivatives	0.776	0.224
W19.9 Unspecified place	0.773	0.227
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.772	0.228
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.770	0.230
Y44 Agents primarily affecting blood constituents	0.768	0.232
W07 Fall involving chair	0.767	0.233
S50-S59 Injuries to the elbow and forearm	0.761	0.239
T51.9 Alcohol, unspecified	0.760	0.240
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.759	0.241
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.759	0.241
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.757	0.243
F10.4 Withdrawal state with delirium	0.754	0.246
F60-F69 Disorders of adult personality and behaviour	0.750	0.250
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.749	0.251
V80-V89 Other land transport accidents	0.748	0.252
T43.5 Other and unspecified antipsychotics and neuroleptics	0.747	0.253
Y54.3 Benzothiadiazine derivatives	0.746	0.254
H11.3 Conjunctival haemorrhage	0.745	0.255
Y57 Other and unspecified drugs and medicaments	0.741	0.259
H20 Iridocyclitis	0.741	0.259
W20-W49 Exposure to inanimate mechanical forces	0.741	0.259
H40 Glaucoma	0.739	0.261
T15-T19 Effects of foreign body entering through natural orifice	0.737	0.263
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.736	0.264
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.736	0.264
H16 Keratitis	0.734	0.266
T20-T25 Burns and corrosions of external body surface, specified by site	0.733	0.267
J00-J06 Acute upper respiratory infections	0.733	0.267
S02 Fracture of skull and facial bones	0.732	0.268
T79.3 Post-traumatic wound infection, not elsewhere classified	0.731	0.269
H55-H59 Other disorders of eye and adnexa	0.731	0.269
S82.4 Fracture of fibula alone	0.726	0.274
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.726	0.274
T00-T07 Injuries involving multiple body regions	0.724	0.276
T51.0 Ethanol	0.723	0.277
H46-H48 Disorders of optic nerve and visual pathways	0.721	0.279
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.721	0.279
H61.2 Impacted cerumen	0.720	0.280
W18 Other fall on same level	0.720	0.280
J46 Status asthmaticus	0.718	0.282
Y43.3 Other antineoplastic drugs	0.713	0.287
J94 Other pleural conditions	0.711	0.289
H81 Disorders of vestibular function	0.710	0.290
J14 Pneumonia due to Haemophilus influenzae	0.710	0.290
J47 Bronchiectasis	0.708	0.292
F52 Sexual dysfunction, not caused by organic disorder or disease	0.707	0.293
S70 Superficial injury of hip and thigh	0.705	0.295
F80-F89 Disorders of psychological development	0.705	0.295
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.705	0.295
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.704	0.296
S06 Intracranial injury	0.703	0.297
T33-T35 Frostbite	0.703	0.297
T26-T28 Burns and corrosions confined to eye and internal organs	0.703	0.297
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.700	0.300
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.700	0.300
T41 Poisoning by anaesthetics and therapeutic gases	0.700	0.300
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.700	0.300
T36 Poisoning by systemic antibiotics	0.700	0.300
J17 Pneumonia in diseases classified elsewhere	0.699	0.300
W17 Other fall from one level to another	0.699	0.301
T56 Toxic effect of metals	0.699	0.301
Chapter XVI Certain conditions originating in the perinatal period	0.698	0.302
Y35-Y36 Legal intervention and operations of war	0.697	0.302
Y10-Y34 Event of undetermined intent	0.697	0.302
Y00-Y09 Assault	0.697	0.302
X85-X99 Assault	0.697	0.302
X58-X59 Accidental exposure to other and unspecified factors	0.697	0.302
X50-X57 Overexertion, travel and privation	0.697	0.302
X30-X39 Exposure to forces of nature	0.697	0.302
X10-X19 Contact with heat and hot substances	0.697	0.302
X00-X09 Exposure to smoke, fire and flames	0.697	0.302
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.697	0.302
W75-W84 Other accidental threats to breathing	0.697	0.302
W65-W74 Accidental drowning and submersion	0.697	0.302
W50-W64 Exposure to animate mechanical forces	0.697	0.302
V98-V99 Other and unspecified transport accidents	0.697	0.302
V95-V97 Air and space transport accidents	0.697	0.302
V90-V94 Water transport accidents	0.697	0.302
V70-V79 Bus occupant injured in transport accident	0.697	0.302
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.697	0.302
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.697	0.302
V40-V49 Car occupant injured in transport accident	0.697	0.302
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.697	0.302
V01-V09 Pedestrian injured in transport accident	0.697	0.302
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.697	0.303
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.697	0.303
E10-E14 Diabetes mellitus	0.696	0.304
Y40.9 Systemic antibiotic, unspecified	0.694	0.306
S89 Other and unspecified injuries of lower leg	0.693	0.307
H17 Corneal scars and opacities	0.691	0.309
T42.4 Benzodiazepines	0.690	0.310
X20-X29 Contact with venomous animals and plants	0.690	0.310
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.689	0.311
J92 Pleural plaque	0.689	0.311
S82.0 Fracture of patella	0.688	0.312
T46 Poisoning by agents primarily affecting the cardiovascular system	0.688	0.312
E23 Hypofunction and other disorders of pituitary gland	0.688	0.312
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.688	0.312
Y59 Other and unspecified vaccines and biological substances	0.687	0.313
Y58 Bacterial vaccines	0.687	0.313
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.687	0.313
Y53 Agents primarily affecting the gastro-intestinal system	0.687	0.313
Y50 Central nervous system stimulants, not elsewhere classified	0.687	0.313
Y49 Psychotropic drugs, not elsewhere classified	0.687	0.313
Y48 Anaesthetics and therapeutic gases	0.687	0.313
Y47 Sedatives, hypnotics and antianxiety drugs	0.687	0.313
Y46 Antiepileptics and anti-Parkinsonism drugs	0.687	0.313
J18.0 Bronchopneumonia, unspecified	0.686	0.314
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.683	0.317
J80-J84 Other respiratory diseases principally affecting the interstitium	0.682	0.318
W16 Diving or jumping into water causing injury other than drowning or submersion	0.682	0.318
W15 Fall from cliff	0.682	0.318
W14 Fall from tree	0.682	0.318
W12 Fall on and from scaffolding	0.682	0.318
W11 Fall on and from ladder	0.682	0.318
W10 Fall on and from stairs and steps	0.682	0.318
W09 Fall involving playground equipment	0.682	0.318
W08 Fall involving other furniture	0.682	0.318
W05 Fall involving wheelchair	0.682	0.318
W04 Fall while being carried or supported by other persons	0.682	0.318
W03 Other fall on same level due to collision with, or pushing by, another person	0.682	0.318
W01 Fall on same level from slipping, tripping and stumbling	0.682	0.318
W00 Fall on same level involving ice and snow	0.682	0.318
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.679	0.321
F70-F79 Mental retardation	0.679	0.321
H50 Other strabismus	0.678	0.322
W19.3 Sports and athletics area	0.678	0.322
T79.6 Traumatic ischaemia of muscle	0.677	0.323
F99 Mental disorder, not otherwise specified	0.677	0.323
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.676	0.324
B25-B34 Other viral diseases	0.675	0.325
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.674	0.326
Y41 Other systemic anti-infectives and antiparasitics	0.674	0.326
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.674	0.326
W19.8 Other specified place	0.673	0.326
W19.5 Trade and service area	0.673	0.326
W19.0 Home	0.673	0.326
W19.7 Farm	0.673	0.326
W19.6 Industrial and construction area	0.673	0.326
W19.1 Residential institution	0.673	0.326
B20-B24 Human immunodeficiency virus [HIV] disease	0.672	0.328
X40-X49 Accidental poisoning by and exposure to noxious substances	0.672	0.328
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.669	0.331
F18 Mental and behavioural disorders due to use of volatile solvents	0.669	0.331
F16 Mental and behavioural disorders due to use of hallucinogens	0.669	0.331
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.669	0.331
F14 Mental and behavioural disorders due to use of cocaine	0.669	0.331
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.669	0.331
F12 Mental and behavioural disorders due to use of cannabinoids	0.669	0.331
F11 Mental and behavioural disorders due to use of opioids	0.669	0.331
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.669	0.331
S71 Open wound of hip and thigh	0.669	0.331
S60 Superficial injury of wrist and hand	0.668	0.332
T66-T78 Other and unspecified effects of external causes	0.667	0.333
S90-S99 Injuries to the ankle and foot	0.665	0.335
T94 Sequelae of injuries involving multiple and unspecified body regions	0.664	0.336
S82.40 Fracture of fibula alone (closed)	0.664	0.336
F10.9 Unspecified mental and behavioural disorder	0.663	0.336
F10.8 Other mental and behavioural disorders	0.663	0.336
F10.7 Residual and late-onset psychotic disorder	0.663	0.336
F10.6 Amnesic syndrome	0.663	0.336
F10.5 Psychotic disorder	0.663	0.336
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.663	0.337
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.661	0.339
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.660	0.339
S05 Injury of eye and orbit	0.660	0.340
H80 Otosclerosis	0.660	0.340
T50.8 Diagnostic agents	0.660	0.340
T50.7 Analeptics and opioid receptor antagonists	0.660	0.340
T50.6 Antidotes and chelating agents, not elsewhere classified	0.660	0.340
T50.5 Appetite depressants	0.660	0.340
T50.4 Drugs affecting uric acid metabolism	0.660	0.340
T50.3 Electrolytic, caloric and water-balance agents	0.660	0.340
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.660	0.340
T50.1 Loop [high-ceiling] diuretics	0.660	0.340
T50.0 Mineralocorticoids and their antagonists	0.660	0.340
H20.9 Iridocyclitis, unspecified	0.658	0.342
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.655	0.345
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.655	0.345
S62 Fracture at wrist and hand level	0.655	0.345
J18.1 Lobar pneumonia, unspecified	0.654	0.346
Y43.0 Antiallergic and antiemetic drugs	0.653	0.347
Y52.4 Angiotensin-converting-enzyme inhibitors	0.652	0.348
B15-B19 Viral hepatitis	0.650	0.350
V20-V29 Motorcycle rider injured in transport accident	0.649	0.351
S10-S19 Injuries to the neck	0.648	0.352
T65 Toxic effect of other and unspecified substances	0.648	0.352
T62 Toxic effect of other noxious substances eaten as food	0.648	0.352
T61 Toxic effect of noxious substances eaten as seafood	0.648	0.352
T60 Toxic effect of pesticides	0.648	0.352
T59 Toxic effect of other gases, fumes and vapours	0.648	0.352
T57 Toxic effect of other inorganic substances	0.648	0.352
T54 Toxic effect of corrosive substances	0.648	0.352
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.648	0.352
T52 Toxic effect of organic solvents	0.648	0.352
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.648	0.352
T58 Toxic effect of carbon monoxide	0.648	0.352
T55 Toxic effect of soaps and detergents	0.648	0.352
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.647	0.353
J12 Viral pneumonia, not elsewhere classified	0.647	0.353
J09 Influenza due to certain identified influenza virus	0.647	0.353
S79 Other and unspecified injuries of hip and thigh	0.646	0.354
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.645	0.354
F10.3 Withdrawal state	0.645	0.355
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.645	0.355
B65-B83 Helminthiases	0.644	0.356
H40.9 Glaucoma, unspecified	0.644	0.356
E27 Other disorders of adrenal gland	0.643	0.357
W23 Caught, crushed, jammed or pinched in or between objects	0.642	0.358
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.641	0.359
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.640	0.360
V10-V19 Pedal cyclist injured in transport accident	0.639	0.361
E34 Other endocrine disorders	0.638	0.361
T92 Sequelae of injuries of upper limb	0.638	0.362
T43.0 Tricyclic and tetracyclic antidepressants	0.638	0.362
H21 Other disorders of iris and ciliary body	0.637	0.363
J11 Influenza, virus not identified	0.636	0.363
F52.2 Failure of genital response	0.636	0.364
S82.6 Fracture of lateral malleolus	0.635	0.365
W07.0 Home	0.635	0.365
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.635	0.365
S82.1 Fracture of upper end of tibia	0.633	0.366
H18 Other disorders of cornea	0.633	0.367
H11.1 Conjunctival degenerations and deposits	0.633	0.367
T91 Sequelae of injuries of neck and trunk	0.633	0.367
S00 Superficial injury of head	0.633	0.367
E29 Testicular dysfunction	0.632	0.368
S88 Traumatic amputation of lower leg	0.632	0.368
S87 Crushing injury of lower leg	0.632	0.368
S86 Injury of muscle and tendon at lower leg level	0.632	0.368
S85 Injury of blood vessels at lower leg level	0.632	0.368
S84 Injury of nerves at lower leg level	0.632	0.368
Y44.2 Anticoagulants	0.632	0.368
H83 Other diseases of inner ear	0.631	0.369
S02.3 Fracture of orbital floor	0.628	0.372
J18.9 Pneumonia, unspecified	0.627	0.373
S69 Other and unspecified injuries of wrist and hand	0.626	0.374
H61.9 Disorder of external ear, unspecified	0.625	0.375
H52 Disorders of refraction and accommodation	0.623	0.377
T45.0 Antiallergic and antiemetic drugs	0.621	0.379
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.620	0.379
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.620	0.380
E50-E64 Other nutritional deficiencies	0.620	0.380
S80 Superficial injury of lower leg	0.620	0.380
F17 Mental and behavioural disorders due to use of tobacco	0.618	0.382
Y43.1 Antineoplastic antimetabolites	0.618	0.382
S66 Injury of muscle and tendon at wrist and hand level	0.617	0.383
Y60-Y69 Misadventures to patients during surgical and medical care	0.617	0.383
Q80-Q89 Other congenital malformations	0.616	0.384
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.616	0.384
T16 Foreign body in ear	0.615	0.385
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.615	0.385
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.615	0.385
H15 Disorders of sclera	0.615	0.385
S02.4 Fracture of malar and maxillary bones	0.614	0.386
H55 Nystagmus and other irregular eye movements	0.614	0.386
F30-F39 Mood [affective] disorders	0.614	0.386
H11.8 Other specified disorders of conjunctiva	0.613	0.387
S08 Traumatic amputation of part of head	0.612	0.388
S07 Crushing injury of head	0.612	0.388
S04 Injury of cranial nerves	0.612	0.388
S03 Dislocation, sprain and strain of joints and ligaments of head	0.612	0.388
S52 Fracture of forearm	0.612	0.388
S72 Fracture of femur	0.612	0.388
T63 Toxic effect of contact with venomous animals	0.612	0.388
X78 Intentional self-harm by sharp object	0.610	0.389
B99-B99 Other infectious diseases	0.610	0.390
H47 Other disorders of optic [2nd] nerve and visual pathways	0.610	0.390
S78 Traumatic amputation of hip and thigh	0.610	0.390
S77 Crushing injury of hip and thigh	0.610	0.390
S76 Injury of muscle and tendon at hip and thigh level	0.610	0.390
S75 Injury of blood vessels at hip and thigh level	0.610	0.390
S74 Injury of nerves at hip and thigh level	0.610	0.390
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.610	0.390
S06.0 Concussion	0.610	0.390
S82.5 Fracture of medial malleolus	0.610	0.390
B85-B89 Pediculosis, acariasis and other infestations	0.610	0.390
B50-B64 Protozoal diseases	0.610	0.390
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.610	0.390
A75-A79 Rickettsioses	0.610	0.390
A70-A74 Other diseases caused by chlamydiae	0.610	0.390
A65-A69 Other spirochaetal diseases	0.610	0.390
A20-A28 Certain zoonotic bacterial diseases	0.610	0.390
A15-A19 Tuberculosis	0.610	0.390
J13 Pneumonia due to Streptococcus pneumoniae	0.609	0.391
F60 Specific personality disorders	0.609	0.391
E23.0 Hypopituitarism	0.607	0.393
J20-J22 Other acute lower respiratory infections	0.607	0.393
S81 Open wound of lower leg	0.607	0.393
S59 Other and unspecified injuries of forearm	0.606	0.394
B35-B49 Mycoses	0.605	0.395
T51.8 Other alcohols	0.605	0.395
T51.3 Fusel oil	0.605	0.395
T51.2 2-Propanol	0.605	0.395
T51.1 Methanol	0.605	0.395
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.605	0.395
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.603	0.397
S68 Traumatic amputation of wrist and hand	0.603	0.397
J06 Acute upper respiratory infections of multiple and unspecified sites	0.603	0.397
D55-D59 Haemolytic anaemias	0.602	0.398
Y85 Sequelae of transport accidents	0.601	0.398
E11 Non-insulin-dependent diabetes mellitus	0.601	0.399
H90-H95 Other disorders of ear	0.601	0.399
H40.0 Glaucoma suspect	0.600	0.400
T47.1 Other antacids and anti-gastric-secretion drugs	0.600	0.400
Y52.1 Calcium-channel blockers	0.600	0.400
H16.9 Keratitis, unspecified	0.599	0.400
S82.00 Fracture of patella (closed)	0.599	0.401
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.599	0.401
Y43.9 Primarily systemic agent, unspecified	0.599	0.401
Y43.8 Other primarily systemic agents, not elsewhere classified	0.599	0.401
Y43.6 Enzymes, not elsewhere classified	0.599	0.401
Y43.5 Acidifying and alkalising agents	0.599	0.401
Y43.4 Immunosuppressive agents	0.599	0.401
Y43.2 Antineoplastic natural products	0.599	0.401
H30-H36 Disorders of choroid and retina	0.599	0.401
Y54.9 Mineral salts, not elsewhere classified	0.598	0.402
Y54.8 Agents affecting uric acid metabolism	0.598	0.402
Y54.7 Agents affecting calcification	0.598	0.402
Y54.6 Electrolytic, caloric and water-balance agents	0.598	0.402
Y54.5 Other diuretics	0.598	0.402
Y54.4 Loop [high-ceiling] diuretics	0.598	0.402
Y54.2 Carbonic-anhydrase inhibitors	0.598	0.402
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.598	0.402
Y54.0 Mineralocorticoids	0.598	0.402
D68 Other coagulation defects	0.598	0.402
E21.3 Hyperparathyroidism, unspecified	0.597	0.403
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.597	0.403
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.597	0.403
T42.5 Mixed antiepileptics, not elsewhere classified	0.597	0.403
T42.3 Barbiturates	0.597	0.403
T42.2 Succinimides and oxazolidinediones	0.597	0.403
T42.1 Iminostilbenes	0.597	0.403
T42.0 Hydantoin derivatives	0.597	0.403
J15.0 Pneumonia due to Klebsiella pneumoniae	0.597	0.403
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.597	0.403
T39.4 Antirheumatics, not elsewhere classified	0.597	0.403
T39.2 Pyrazolone derivatives	0.597	0.403
H16.0 Corneal ulcer	0.597	0.403
E22 Hyperfunction of pituitary gland	0.596	0.404
H61.0 Perichondritis of external ear	0.596	0.404
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.596	0.404
E26 Hyperaldosteronism	0.595	0.405
Y40.3 Macrolides	0.595	0.405
Y57.8 Other drugs and medicaments	0.594	0.406
D80-D89 Certain disorders involving the immune mechanism	0.594	0.406
J01 Acute sinusitis	0.594	0.406
H13 Disorders of conjunctiva in diseases classified elsewhere	0.594	0.406
H62 Disorders of external ear in diseases classified elsewhere	0.593	0.406
T43.9 Psychotropic drug, unspecified	0.593	0.407
T43.8 Other psychotropic drugs, not elsewhere classified	0.593	0.407
T43.6 Psychostimulants with abuse potential	0.593	0.407
T43.4 Butyrophenone and thioxanthene neuroleptics	0.593	0.407
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.593	0.407
B97 Viral agents as the cause of diseases classified to other chapters	0.593	0.407
S01 Open wound of head	0.592	0.408
J15.1 Pneumonia due to Pseudomonas	0.591	0.409
Y56.9 Topical agent, unspecified	0.590	0.410
Y56.8 Other topical agents	0.590	0.410
Y56.7 Dental drugs, topically applied	0.590	0.410
Y56.6 Otorhinolaryngological drugs and preparations	0.590	0.410
Y56.5 Ophthalmological drugs and preparations	0.590	0.410
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.590	0.410
Y56.3 Emollients, demulcents and protectants	0.590	0.410
Y56.2 Local astringents and local detergents	0.590	0.410
Y56.1 Antipruritics	0.590	0.410
H82 Vertiginous syndromes in diseases classified elsewhere	0.589	0.410
H40.2 Primary angle-closure glaucoma	0.590	0.410
J95-J99 Other diseases of the respiratory system	0.589	0.410
Q38-Q45 Other congenital malformations of the digestive system	0.589	0.410
U80 Agent resistant to penicillin and related antibiotics	0.589	0.411
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.589	0.411
J43 Emphysema	0.589	0.411
S82.2 Fracture of shaft of tibia	0.588	0.412
J15.4 Pneumonia due to other streptococci	0.588	0.412
S02.0 Fracture of vault of skull	0.587	0.412
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.586	0.414
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.586	0.414
T98 Sequelae of other and unspecified effects of external causes	0.586	0.414
H11.9 Disorder of conjunctiva, unspecified	0.585	0.415
H65-H75 Diseases of middle ear and mastoid	0.585	0.415
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.585	0.415
Y52.8 Antivaricose drugs, including sclerosing agents	0.585	0.415
Y52.7 Peripheral vasodilators	0.585	0.415
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.585	0.415
Y52.3 Coronary vasodilators, not elsewhere classified	0.585	0.415
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.585	0.415
T79.9 Unspecified early complication of trauma	0.584	0.416
T79.8 Other early complications of trauma	0.584	0.416
T79.7 Traumatic subcutaneous emphysema	0.584	0.416
T79.5 Traumatic anuria	0.584	0.416
T79.4 Traumatic shock	0.584	0.416
T79.2 Traumatic secondary and recurrent haemorrhage	0.584	0.416
T79.1 Fat embolism (traumatic)	0.584	0.416
T79.0 Air embolism (traumatic)	0.584	0.416
S82.9 Fracture of lower leg, part unspecified	0.583	0.417
S82.7 Multiple fractures of lower leg	0.583	0.417
J15.2 Pneumonia due to staphylococcus	0.582	0.417
S70.1 Contusion of thigh	0.581	0.419
J18.8 Other pneumonia, organism unspecified	0.580	0.420
J18.2 Hypostatic pneumonia, unspecified	0.580	0.420
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.580	0.420
E28 Ovarian dysfunction	0.580	0.420
H42 Glaucoma in diseases classified elsewhere	0.580	0.420
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.579	0.421
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.579	0.421
F51 Nonorganic sleep disorders	0.579	0.421
F50 Eating disorders	0.579	0.421
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.579	0.421
F55 Abuse of non-dependence-producing substances	0.579	0.421
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.579	0.421
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.579	0.421
T95 Sequelae of burns, corrosions and frostbite	0.578	0.422
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.578	0.422
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.578	0.422
S65 Injury of blood vessels at wrist and hand level	0.578	0.422
H81.1 Benign paroxysmal vertigo	0.578	0.422
J10 Influenza due to identified influenza virus	0.576	0.424
J80 Adult respiratory distress syndrome	0.575	0.425
B02 Zoster [herpes zoster]	0.573	0.427
H17.9 Corneal scar and opacity, unspecified	0.572	0.428
H81.2 Vestibular neuronitis	0.571	0.429
W23.2 School, other institution and public administrative area	0.571	0.429
E11.5 With peripheral circulatory complications	0.571	0.429
E40-E46 Malnutrition	0.571	0.429
S50 Superficial injury of forearm	0.570	0.430
E35 Disorders of endocrine glands in diseases classified elsewhere	0.569	0.431
E32 Diseases of thymus	0.569	0.431
E31 Polyglandular dysfunction	0.569	0.431
E30 Disorders of puberty, not elsewhere classified	0.569	0.431
E25 Adrenogenital disorders	0.569	0.431
E24 Cushing's syndrome	0.569	0.431
E20 Hypoparathyroidism	0.569	0.431
T93 Sequelae of injuries of lower limb	0.569	0.431
B34 Viral infection of unspecified site	0.569	0.431
H61.8 Other specified disorders of external ear	0.568	0.432
S60.9 Superficial injury of wrist and hand, unspecified	0.568	0.432
J41 Simple and mucopurulent chronic bronchitis	0.566	0.433

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations